Clinical Trials on Zoster Varicella

Total 1028 results

Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

An Immunity Persistence Study of Live Attenuated Varicella Vaccine

Varicella

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Varicella

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age

Varicella

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Varicella

China
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Second Dose of Biken's Varicella Vaccine

Varicella

Argentina
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

HIV Infections | Chickenpox

United States
GlaxoSmithKline

Completed

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Chickenpox | Chicken-pox Illness (Varicella Virus Disease)

Estonia, Thailand, Germany, Mexico, United Kingdom
Shahid Beheshti University of Medical Sciences

Unknown

Efficacy of TCA Effect on Varicella Atrophic Scars

Atrophic Varicella Scar

Iran, Islamic Republic of
The University of Texas Medical Branch, Galveston
Shriners Hospitals for Children

Completed

Review of Human Herpes Viruses in Burns

Burns | Chickenpox | Cytomegalovirus | Herpes Simplex Virus | Varicella-zoster Virus | Human Herpes Virus
Cangene Corporation

Approved for marketing

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

Varicella
Oklahoma Medical Research Foundation

Completed

Safety of Zostavax Vaccination in Rheumatoid Arthritis

Rheumatoid Arthritis | Varicella Zoster

United States
Radboud University Medical Center

Terminated

Pharmacokinetics of Valacyclovir Oral Solution in Children (VALID2)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
Zhuhai Trinomab Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy

Varicella

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Varicella
Merck Sharp & Dohme LLC

Completed

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

Varicella
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

Herpes Zoster | Herpes Zoster-related Complications
The Hospital for Sick Children

Completed

The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation

Organ Transplantation | Immunosuppression

Canada
The Center for the Biology of Chronic Disease

Completed

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Epstein-Barr Virus Infections | Cytomegalovirus Infections | Human Papillomavirus | Herpes Simplex Infections | Varicella-zoster Virus Infection

United States
University of Colorado, Denver

Withdrawn

Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine.

Varicella | Transplants
University Hospital, Geneva

Recruiting

Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients (VZVinOLTx)

Liver Disease | Varicella | Immunosuppression

Switzerland
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

Varicella
Susanne Dam Nielsen, MD, DMSc
Rigshospitalet, Denmark; Technical University of Denmark

Recruiting

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study (HISTORY)

Varicella Zoster Virus Infection | Cytomegalovirus Infections | Liver Transplant; Complications

Denmark
Merck Sharp & Dohme LLC

Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Varicella

Russian Federation
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Varicella

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Varicella
GlaxoSmithKline

Completed

Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

Hepatitis A | Cytomegalovirus | Bordetella Pertussis Infection | Viral Hepatitis Vaccines | Varicella-Zoster Virus | Herpes Simplex (1 and 2)

Mexico
Vinmec Healthcare System

Withdrawn

Regional Anesthesia to Relief Zoster Pain

Zoster Without Complications

Vietnam
Innovaderm Research Inc.
Merck Sharp & Dohme LLC

Terminated

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Psoriasis

Canada
Seoul National University Hospital

Completed

Optimal Timing of Zoster Vaccine After Zoster Illness

Shingles

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Prevention of : Herpes-Zoster
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Varicella-Zoster Vaccination and Infection

Herpes Zoster | Chickenpox

United States
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

Herpes Zoster Pain

China
Green Cross Corporation

Completed

Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults

Varicella (Chicken Pox)
Radboud University Medical Center

Completed

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID-I)

Varicella Zoster Virus Infection | Herpes Simplex Virus Infection

Netherlands
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Completed

PREPARE-iVAC Trial (PREPARE-iVAC)

Vaccine Response | Immunosuppression | COVID-19 Vaccines | Varicella Zoster Vaccine

Netherlands
Central Adelaide Local Health Network Incorporated
National Health and Medical Research Council, Australia; University of Adelaide and other collaborators

Not yet recruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Kidney Transplant Recipients (SIR ZOSTER)

Immunosuppression | Vaccine Response Impaired
Pfizer

Recruiting

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Shingles | Human | Herpes Zoster Infection

United States
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
University of Tennessee
Merck Sharp & Dohme LLC; American Pharmacists Association

Completed

The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting

Herpes Zoster

United States
EyeGene Inc.
Novotech (Australia) Pty Limited

Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Prevention of Herpes Zoster (HZ)

Australia
ContraVir Pharmaceuticals, Inc.

Completed

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

Acute Herpes Zoster
EuBiologics Co.,Ltd

Not yet recruiting

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

Herpes Zoster | Varicella Zoster Virus Infection
Odense University Hospital

Completed

Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCT

Chronic Pain | Herpes Zoster | Postherpetic Neuralgia | Shingles | Varicella Zoster

Denmark
Loyola University

Not yet recruiting

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Shingles
University of Washington
Merck Sharp & Dohme LLC

Completed

Immune Response to Shingles Vaccination

Shingles

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Tulane University

Completed

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Fibrosis | Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

Shingles

Clinical Trials on Zoster Varicella

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations